Sklawer Andrew D is President and CEO of Fresh Tracks Therapeutics, Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Fresh Tracks Therapeutics, Inc.
4 Oct 23
4
Fresh Tracks Therapeutics, Inc.
26 Jan 23
4
Brickell Biotech, Inc.
9 May 22
4
Brickell Biotech, Inc.
14 Jun 21
4
Brickell Biotech, Inc.
19 May 21
4
Brickell Biotech, Inc.
17 Mar 21
4
Brickell Biotech, Inc.
16 Sep 20
4
Brickell Biotech, Inc.
22 Jun 20
4
Brickell Biotech, Inc.
18 Mar 20
3
Brickell Biotech, Inc.
9 Sep 19
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
2 Oct 23 | FRTX Fresh Tracks Therapeutics | Common Stock | Payment of exercise | Dispose F | No | No | 0.9798 | 20,833 | 20.41 k | 39,269 |
2 Oct 23 | FRTX Fresh Tracks Therapeutics | Common Stock | Option exercise | Acquire M | No | No | 0 | 55,000 | 0.00 | 60,102 |
2 Oct 23 | FRTX Fresh Tracks Therapeutics | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 55,000 | 0.00 | 0 |
24 Jan 23 | FRTX Fresh Tracks Therapeutics | RSU Common Stock | Grant | Acquire A | No | No | 0 | 55,000 | 0.00 | 55,000 |